retatrutide nonalcoholic steatohepatitis trial Results: 28.3% Weight Loss Data Triple hormone receptor agonist retatrutide

Declining Surgical Volumes Stratas analysis of data from 809 hospitals nationwide shows a clear downward trend in bariatric surgeries

If you are still deciding whether treatment is a fit for you, you can take the free assessment quiz to see whether a personalized program makes sense for your goals

A waiver of consent was approved because of the retrospective nature of the study with a large number of patients and due to the research involving no more than minimal risk (including privacy risks) to the individuals

05.02.25 MDL numbers increased leading into May The Ozempic MDL increased to 1,809 pending actions

Medical weight loss programs may include: Custom nutrition plans with a registered dietitian